Register for NLARx Winter Meeting Join us in Washington DC on February 26. On the agenda: State legislation, Federal Rx and PBM reform; GAO price report; trade policy and state Medicaid costs, kids and psychotropics. Register here
In the States Maine - Discarded Drugs Frequently Taint Water Supplies
more Unused Drugs Bill Moves Ahead more Rx Disposal Bill Worthy of Passage
more Minnesota - Pharma Marketing Research Gains Tenuous Hold more Mississippi - Mississippi Settles Zyprexa Suit for $18.5M more New Jersey - Medicaid Costs Raise State Deficit Nearly $200M more AG Proposes Gift Ban Rules more Psychotropics Informed Consent Bill more Tennessee - Hospitals: TennCare Cuts Could Close Doors on Ailing Facilities more Virginia - Medicaid Cuts to Further Pinch Ailing Providers more
Outrage of the Week Dumbest PowerPoint Ever? J&J's Slideshow of Alleged Kickback Scheme more
Psychiatric Meds and Diagnosis Generation Rx more Children Labeled 'Bipolar' May Get A New Diagnosis more Accutane, Depression And Expert Testimony more Doctors Cautioned On Zyprexa For Adolescents more Informed Consent Bill On Psychotropics Back In NJ more
Pharmaceuticals & Health Reform Web-Based Records Worried Patients, Prompting More Neutral Language more Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo more
Prices and Access to Health Care
Spending On Prescription Drugs Rose 5.2% In 2009 more Denver Boy Died After State-Benefits Error Denied Him Asthma Medication more Study: Higher Co-Pays Mean More Trips to the Hospital more Increased Cost Sharing May Hurt Seniors' Health Care more NCPA Backs Federal Employee Benefits Bill, Makes Recommendations more GlaxoSmithkline's Malaria Plan: Limit Profits, Open Labs
more Ireland: Cost of 300 commonly prescribed drugs to drop by 40% from today more UK's NICE Rejects Three Cancer Drugs Over Cost more Philippines to Announce Second Drug Price-Cut List more
Fraud and Abuse Lilly-Zyprexa: $18.5 Million Settlement in Mississippi more Vioxx Lawsuits: What's Been Settled, What's Still Going? more Merck, Pfizer Overcharged New York, Judge Rules more
Conflicts of Interest How See-Through are These Disclosures? more Cephalon Discloses Payments To Doctors more Ghostwriting at Elite Academic Medical Centers in the United States more Inside Medicine: Samples of Drugs Aren't Free more F.D.A. Aims at Doctors' Drug Pitches more Conflicts of Interest Comes To A Talk Show Near You more Eli Lilly Exec Heads to Harvard Med School more
Advertising and Marketing The Rise Of Marketing-Based Medicine more Lilly: "Execute the *%#&*! Out of Them! more Did Cephalon Pay James Mcmillen $101,650 to Help Promote Actiq for Off-Label Use? more The Lancet - The Perils of Journal and Supplement Publishing more Under More Pressure, Drug Ads Replace Sassy With Serious more Health Debate Travails Boost Lobbying Firms more Ten Misleading Drug Ads more A Pharma "Social Media Working Group" Submits Comments to FDA more Novartis Pays $185M Fine For Off-Label Marketing more F.D.A. Aims at Doctors' Drug Pitches more Drug Marketing Remains an Issue more
PBM Watch CVS Net Rises on 90-Day Prescription Sales at Stores more Why Pharma's Patent Cliff Is Good News for Pharmacies more Medco Says 'Specialist Pharmacists' Can Help Docs Recognize PGx Opportunities for Oncology Patients more Express Scripts to Spin-off Rx Outreach to Create Nonprofit Offering Prescription Medicines more
Pharma Watch Senate Committee approves nomination of Julie Brill and Edith Ramirez to the FTC more FTC Wants More Staff To Tackle Biopharma Mergers more Merck Agrees To Boost Drug-Safety Procedures more 'Corrupt' Drug Firm Practices Exposed more Government Cracks Down On Drug Marketing more Judge Refuses to Dismiss Fosamax Case, Sets Trial more Drug Company CEOs Under Pressure more Ethics: Rules Reveal Doctors' Priorities more AZ faces $1.2B in Seroquel legal costs more Seroquel Pain more Big Pharma's Best Chief Steps Down more
Patents and Generics Policy Making on Data Exclusivity in the European Union more Recent Rulings Shine the Light on Sham Citizen Petition Antitrust Issues more Cephalon, Like Big Pharma, Looks to Global Generics for Growth more Generic Drugs May Reach U.S. Market Sooner With Proposed Fees more FTC Report Blasts Pharma 'Pay-Offs' more
Medicare and Medicaid Cancer Treatment Will Suffer Without Action on Medicare more California, Nevada Officials Outline Dire Medicaid Scenarios more CMS' New Drug Spending Projections more Teva Settles Medicaid Pricing Lawsuits more Millions More Children Added To Medicaid, CHIP Rolls In 2009 more Medicaid Cuts Concern Businesses And Patient Advocates more Won't Get FULed Again more States Cutting Back Special Programs For The Uninsured more Ohio Changes Medicaid Drug Program more Mich., R.I. Look For Cuts In Medicaid Costs more Survey: Medicaid Beats Private Insurance When It Comes To Prevention more State Budget News From Kansas, Massachusetts and Idaho more
Safety and Clinical Trials FDA Acts Faster on Drug-Ad Missteps more FDA Warnings Double In Obama's First Year more No Real New Money for Drug Regulation more Paxil Linked To Deaths In Breast Cancer Patients more FDA Vows To Screen High-Risk Drugs more Pick Your Poison more Some States Mull Requiring Prescription For Meth Ingredients more Roche Wins 'Shame' Prizes For Research In China more Is M&A Frenzy Short-Circuiting Pharma R&D? more Requests for Orphan Drug Designation Explode in 2009; But Designation Success Rate is Low more Doubts Build On Glaxo's Antiaging Drugs
more
